Nasin (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nasin, is a alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It provides temporary relief of nasal congestion associated with the common cold, sinusitis and allergic rhinitis.\n\nGNH India supplies Nasin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride is an alpha‑adrenergic agonist used to relieve nasal congestion in several common upper‑respiratory conditions.\n\n- Common cold: temporary relief of nasal congestion associated with viral upper‑respiratory infection.\n- Sinusitis: reduction of mucosal swelling to improve sinus drainage and breathing.\n- Allergic rhinitis: alleviation of nasal blockage caused by allergen‑induced inflammation.

Nasin may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Nasal irritation or burning sensation\n- Dryness of the nasal mucosa\n- Sneezing\n- Mild headache\n- Altered taste sensation\n- Transient epistaxis\n\nSerious or Rare Side Effects:\n- Rebound nasal congestion (rhinitis medicamentosa)\n- Significant elevation of blood pressure\n- Tachycardia or arrhythmia\n- Severe allergic reaction (anaphylaxis)\n- Ocular effects such as blurred vision\n- Nasal ulceration

Before using Nasin, consider the following safety measures.\n\n- Duration of use: limit to no more than three consecutive days to avoid rebound congestion.\n- Cardiovascular conditions: avoid if you have uncontrolled hypertension or severe coronary artery disease.\n- Children: not recommended for children under the age specified on the label unless directed by a healthcare professional.\n- Pregnancy and breastfeeding: consult a healthcare provider before use.\n- Drug interactions: review potential interactions with other medications (see Interactions section).\n- Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline may interact with other agents that affect the cardiovascular system or nasal vasculature.\n\nMajor Interactions (Avoid):\n- Other topical nasal decongestants: risk of excessive vasoconstriction and tissue damage.\n- Systemic sympathomimetics (e.g., pseudoephedrine): additive cardiovascular stimulation.\n- Monoamine oxidase inhibitors (MAOIs): potential for hypertensive crisis.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: may blunt compensatory tachycardia.\n- Tricyclic antidepressants: possible increase in blood pressure.\n- Clonidine: may reduce antihypertensive effect of clonidine.